Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The connector enhancer of KSR (CNK) is a multidomain scaffold protein discovered in Drosophila, where it is necessary for Ras activation of the Raf kinase. Recent studies have shown that
CNK1
also interacts with RalA and Rho and participates in some aspects of signaling by these GTPases. Herein we demonstrate a novel aspect of
CNK1
function, i.e. reexpression of
CNK1
suppresses tumor cell growth and promotes apoptosis. As shown previously for apoptosis induced by Ki-Ras(G12V),
CNK1
-induced apoptosis is suppressed by a dominant inhibitor of the mammalian sterile 20 kinases 1 and (MST1/MST2). Immunoprecipitates of MST1 endogenous to LoVo
colon cancer
cells contain endogenous
CNK1
; however, no association of these two polypeptides can be detected in a yeast two-hybrid assay.
CNK1
does, however, bind directly to the RASSF1A and RASSF1C polypeptides, constitutive binding partners of the MST1/2 kinases. Deletion of the MST1 carboxyl-terminal segment that mediates its binding to RASSF1A/C eliminates the association of MST1 with
CNK1
. Coexpression of
CNK1
with the tumor suppressive isoform, RASSF1A, greatly augments
CNK1
-induced apoptosis, whereas the nonsuppressive RASSF1C isoform is without effect on
CNK1
-induced apoptosis. Overexpression of
CNK1
-(1-282), a fragment that binds RASSF1A but is not proapoptotic, blocks the apoptosis induced by
CNK1
and by Ki-Ras(G12V). Thus, in addition to its positive role in the proliferative outputs of active Ras, the
CNK1
scaffold protein, through its binding of a RASSF1A.MST complex, also participates in the proapoptotic signaling initiated by active Ras.
...
PMID:The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death. 1507 35